Lataa...
Clinical trial designs incorporating predictive biomarkers()
Development of oncologic therapies has traditionally been performed in a sequence of clinical trials intended to assess safety (phase I), preliminary efficacy (phase II), and improvement over the standard of care (phase III) in homogeneous (in terms of tumor type and disease stage) patient populatio...
Tallennettuna:
| Julkaisussa: | Cancer Treat Rev |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4737867/ https://ncbi.nlm.nih.gov/pubmed/26827695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2015.12.008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|